SHAREHOLDER ALERT: The Law Firm Of Levi & Korsinsky, LLP Launches An Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Directors Of Raptor Pharmaceuticals Corp.

Levi & Korsinsky, LLP is investigating Raptor Pharmaceuticals Corp. (NasdaqGM: RPTP), and its Board of Directors, in connection with possible breaches of fiduciary duty.

To get more information, click here: http://zlk.9nl.com/raptor-pharmaceuticals-rptp/. There is no cost or obligation to you.

If you own common stock in Raptor Pharmaceuticals Corp. and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/raptor-pharmaceuticals-rptp/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010

If you liked this article you might like

Drug Win for Depomed Could Be Hurdle for Starboard

Arbor and Purdue Seen as Likely Bidders for DepoMed

More Rare Disease Dealmaking to Follow Horizon's Raptor Deal

Fed Dove Brainard Pushes Stocks Into Rally Mode

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar